Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clozapine in Huntington's chorea

U Bonuccelli1, R Ceravolo, C Maremmani

  • 1Institute of Clinical Neurology, University of Pisa, Italy.

Neurology
|May 1, 1994
PubMed
Summary

Clozapine effectively reduced abnormal involuntary movements in Huntington's chorea patients. All participants reported improvements in daily activities and requested continued treatment, showing a dose-dependent response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomechanical parameters assessment for the classification of Parkinson Disease using Bidirectional Long Short-Term Memory<sup>.</sup>

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
Same author

Wearable Sensors for Prodromal Motor Assessment of Parkinson's Disease using Supervised Learning.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
Same author

Fine Motor Assessment With Unsupervised Learning For Personalized Rehabilitation in Parkinson Disease.

IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2019
Same author

Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.

Acta neurologica Scandinavica·2017
Same author

'Airlplane headache' with aura.

Cephalalgia : an international journal of headache·2009
Same author

'INDOTEST' in atypical hemicrania continua.

Cephalalgia : an international journal of headache·2008

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Huntington's chorea is a neurodegenerative disorder characterized by abnormal involuntary movements (chorea).
  • Current treatments for chorea in Huntington's disease have limitations and significant side effects.

Purpose of the Study:

  • To evaluate the efficacy of clozapine in reducing chorea in patients with Huntington's disease.
  • To assess the safety and tolerability of clozapine for this indication.

Main Methods:

  • An open-label trial involving five patients with Huntington's chorea.
  • Clozapine was administered at escalating doses (25, 50, 150 mg/d) over three weeks.
  • Abnormal Involuntary Movements Scale (AIMS) and subjective patient self-evaluations were used for assessment.

Main Results:

Related Experiment Videos

  • All patients reported subjective improvements in chorea and daily living activities.
  • Objective AIMS scores showed moderate-to-marked reductions in involuntary movements.
  • Improvements were dose-dependent and diminished one week after drug withdrawal, with no significant side effects observed.

Conclusions:

  • Clozapine demonstrates significant efficacy in reducing chorea in Huntington's disease patients.
  • The drug was well-tolerated, and patients expressed a desire for continued treatment.
  • Further research into clozapine for Huntington's chorea is warranted.